NDC Package 0074-4014-12 Kaletra
Lopinavir And Ritonavir Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm
Package Information
Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.
- RxCUI: 311369 - lopinavir 80 MG / ritonavir 20 MG in 1 mL Oral Solution
- RxCUI: 311369 - lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution
- RxCUI: 311369 - lopinavir 400 MG / ritonavir 100 MG per 5 ML Oral Solution
- RxCUI: 311369 - lopinavir 80 MG / ritonavir 20 MG per 1 ML Oral Solution
- RxCUI: 597730 - lopinavir 200 MG / ritonavir 50 MG Oral Tablet
- Breast Cancer Resistance Protein Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 1A2 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2B6 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C19 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C9 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2D6 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inhibitor - [EPC] (Established Pharmacologic Class)
- Cytochrome P450 3A Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A4 Inhibitors - [MoA] (Mechanism of Action)
- HIV Protease Inhibitors - [MoA] (Mechanism of Action)
- Organic Anion Transporting Polypeptide 1B1 Inhibitors - [MoA] (Mechanism of Action)
- P-Glycoprotein Inhibitors - [MoA] (Mechanism of Action)
- Protease Inhibitor - [EPC] (Established Pharmacologic Class)
- UDP Glucuronosyltransferases Inducers - [MoA] (Mechanism of Action)
- 0074 - Abbvie Inc.
- 0074-4014 - Kaletra
- 0074-4014-12 - 120 TABLET, FILM COATED in 1 BOTTLE
- 0074-4014 - Kaletra
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
Frequently Asked Questions
What is NDC 0074-4014-12?
The NDC Packaged Code 0074-4014-12 is assigned to a package of 120 tablet, film coated in 1 bottle of Kaletra, a human prescription drug labeled by Abbvie Inc.. The product's dosage form is tablet, film coated and is administered via oral form.
Is NDC 0074-4014 included in the NDC Directory?
Yes, Kaletra with product code 0074-4014 is active and included in the NDC Directory. The product was first marketed by Abbvie Inc. on April 08, 2020 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.
What is the NDC billing unit for package 0074-4014-12?
The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 120.
What is the 11-digit format for NDC 0074-4014-12?
The 11-digit format is 00074401412. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.
This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:
10-Digit Format | 10-Digit Original Code | 11-Digit Format | 11-Digit Code |
---|---|---|---|
4-4-2 | 0074-4014-12 | 5-4-2 | 00074-4014-12 |